A novel transcriptomic-based classifier for senescent cancer cells

Abstract

The inability to unequivocally identify senescent cancer cells is hindering the development of novel anticancer therapies using senolytic compounds. In a recent study in Cell Reports, Jochems et al. used a machine-learning approach to generate a classifier for senescent cancer cells based on transcriptional signatures.